Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome.

[1]  G. Ardissino,et al.  Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. , 2017, Kidney international.

[2]  A. Asif,et al.  Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab , 2016, Journal of Nephrology.

[3]  M. Nangaku,et al.  Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis. , 2016, Clinical advances in hematology & oncology : H&O.

[4]  P. Ruggenenti,et al.  Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  V. Frémeaux-Bacchi,et al.  Defining the genetics of thrombotic microangiopathies. , 2016, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[6]  G. Ardissino,et al.  Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome. , 2016, Kidney international.

[7]  G. Ardissino,et al.  The global aHUS registry: methodology and initial patient characteristics , 2015, BMC Nephrology.

[8]  W. Park,et al.  Atypical hemolytic uremic syndrome: Korean pediatric series , 2015, Pediatrics international : official journal of the Japan Pediatric Society.

[9]  G. Remuzzi,et al.  Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies , 2015, Kidney international.

[10]  R. Coppo,et al.  An international consensus approach to the management of atypical hemolytic uremic syndrome in children , 2015, Pediatric Nephrology.

[11]  J. Hofer,et al.  Extra-Renal Manifestations of Complement-Mediated Thrombotic Microangiopathies , 2014, Frontiers in Pediatrics.

[12]  J. George,et al.  Syndromes of thrombotic microangiopathy. , 2014, The New England journal of medicine.

[13]  A. Sinha,et al.  Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children. , 2014, Kidney international.

[14]  G. Remuzzi,et al.  Cardiovascular complications in atypical haemolytic uraemic syndrome , 2014, Nature Reviews Nephrology.

[15]  G. Remuzzi,et al.  Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. , 2013, The New England journal of medicine.

[16]  L. Rostaing,et al.  Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[17]  John Hwa,et al.  Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome , 2013, Nature Genetics.

[18]  A. Janecke,et al.  Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[19]  G. Remuzzi,et al.  Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[20]  E. Rondeau,et al.  Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations. , 2010, Journal of the American Society of Nephrology : JASN.

[21]  Giuseppe Remuzzi,et al.  Atypical hemolytic-uremic syndrome. , 2009, The New England journal of medicine.

[22]  G. Ariceta,et al.  Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome , 2009, Pediatric nephrology (Berlin, West).

[23]  P. Zipfel,et al.  Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency. , 2008, Blood.